They don't dose if there's a problem.
That's why the trial design uses sequential dosing of the first two cohorts.
So second dosing of first cohort means all's well.
I agree we could get a share price pop, especially looking at the valuation variance with Alnylam recently. Traders love this stock if the technical conditions are right.
BLT Price at posting:
95.0¢ Sentiment: Buy Disclosure: Held